New study finds that photoacoustic microscopy (PAM) technique allows researchers to examine the metabolic traits of cancer cells with laser light and high-frequency ultrasonic sensing. The findings of the study are published in the journal Nature Biomedical Engineering.
Devising the best treatment for a patient with cancer requires doctors to know something about the traits of cancer from which the patient is suffering. But one of the greatest difficulties in treating cancer is that cancer cells are not all the same. Even within the same tumor, cancer cells can differ in their genetics, behavior, and susceptibility to chemotherapy drugs.
New Laser Technology Helps Diagnose Colorectal Cancer Early
A novel quantum cascade laser-based infrared (IR) microscope has been developed that helps in the early diagnosis of colorectal cancer.
Advertisement
‘Using photoacoustic microscopy (PAM), a technique in which laser light produces ultrasonic vibrations, metabolic characteristics of cancer cells can be easily distinguished as those vibrations are used to image cells, blood vessels, and tissues. This new technology can soon help doctors make informed decisions on cancer prognosis and therapy.’
Read More..
Tweet it Now
Read More..
Cancer cells are generally much more metabolically active than healthy cells, and some insights into a cancer cell's behavior can be gleaned by analyzing its metabolic activity. But getting an accurate assessment of these characteristics has proven difficult for researchers. Several methods, including position emission tomography (or PET) scans, fluorescent dyes, and contrasts have been used, but each has drawbacks that limit their usefulness.
Caltech's Lihong Wang believes he can do better through the use of photoacoustic microscopy (PAM), a technique in which laser light induces ultrasonic vibrations in a sample. Those vibrations can be used to image cells, blood vessels, and tissues.
![New Web Tool Can Predict Need for Treatment in Early Prostate Cancer]( "New Web Tool Can Predict Need for Treatment in Early Prostate Cancer")
A new web tool, PREDICT Prostate, can accurately predict the prognosis and need for treatment in patients with early-stage prostate cancer by stratifying patients based on survival.
Wang, Bren Professor of Medical Engineering and Electrical Engineering, is using PAM to improve on existing technology for measuring the oxygen-consumption rate (OCR) in collaboration with Professor Jun Zou at Texas A&M University. That existing technology takes many cancer cells and places them each into individual "cubbies" filled with blood. Cells with higher metabolisms will use up more oxygen and will lower the blood oxygen level, a process which is monitored by a tiny oxygen sensor placed inside each cubby.
This method, like those previously mentioned, has weaknesses. To get a meaningful sample size of metabolic data for cancer cells would require researchers to embed thousands of sensors into a grid. Additionally, the presence of the sensors within the cubbies can alter the metabolic rates of the cells, causing the collected data to be inaccurate.
Wang's improved version does away with the oxygen sensors and instead uses PAM to measure the oxygen level in each cubby. He does this with laser light that is tuned to a wavelength that the hemoglobin in the blood absorbs and converts into vibrational energy sound. As a hemoglobin molecule becomes oxygenated, its ability to absorb light at that wavelength changes. Thus, Wang can determine how oxygenated a sample of blood is by "listening" to the sound it makes when illuminated by the laser. He calls this single-cell metabolic photoacoustic microscopy or SCM-PAM.
In a new paper, Wang and his co-authors show that SCM-PAM represents a huge improvement in the ability to assess the OCR of cancer cells. Using individual oxygen sensors to measure OCR limited researchers in analyzing roughly 30 cancer cells every 15 minutes. Wang's SCM-PAM improves that by two orders of magnitude and allows researchers to analyze around 3,000 cells in about 15 minutes. "We have techniques to improve the throughput further by orders of magnitude, and we hope this new technology can soon help physicians make informed decisions on cancer prognosis and therapy," says Wang.
Source: Eurekalert
New Web Tool Can Predict Need for Treatment in Early Prostate Cancer
A new web tool, PREDICT Prostate, can accurately predict the prognosis and need for treatment in patients with early-stage prostate cancer by stratifying patients based on survival.
Advertisement
Wang, Bren Professor of Medical Engineering and Electrical Engineering, is using PAM to improve on existing technology for measuring the oxygen-consumption rate (OCR) in collaboration with Professor Jun Zou at Texas A&M University. That existing technology takes many cancer cells and places them each into individual "cubbies" filled with blood. Cells with higher metabolisms will use up more oxygen and will lower the blood oxygen level, a process which is monitored by a tiny oxygen sensor placed inside each cubby.
This method, like those previously mentioned, has weaknesses. To get a meaningful sample size of metabolic data for cancer cells would require researchers to embed thousands of sensors into a grid. Additionally, the presence of the sensors within the cubbies can alter the metabolic rates of the cells, causing the collected data to be inaccurate.
Wang's improved version does away with the oxygen sensors and instead uses PAM to measure the oxygen level in each cubby. He does this with laser light that is tuned to a wavelength that the hemoglobin in the blood absorbs and converts into vibrational energy sound. As a hemoglobin molecule becomes oxygenated, its ability to absorb light at that wavelength changes. Thus, Wang can determine how oxygenated a sample of blood is by "listening" to the sound it makes when illuminated by the laser. He calls this single-cell metabolic photoacoustic microscopy or SCM-PAM.
In a new paper, Wang and his co-authors show that SCM-PAM represents a huge improvement in the ability to assess the OCR of cancer cells. Using individual oxygen sensors to measure OCR limited researchers in analyzing roughly 30 cancer cells every 15 minutes. Wang's SCM-PAM improves that by two orders of magnitude and allows researchers to analyze around 3,000 cells in about 15 minutes. "We have techniques to improve the throughput further by orders of magnitude, and we hope this new technology can soon help physicians make informed decisions on cancer prognosis and therapy," says Wang.
Source: Eurekalert
Novel Lab-on-a-chip Device Detects Cancer Faster
Cancer can be detected early with this unique lab-on-a-chip test design that helps detect cancer cells by a rapid non-invasive test using a sample of blood plasma. The test can be used to detect other cancers (breast and colorectal) and neurodegenerative diseases.
Advertisement
 New Mobile App Uses Artificial Intelligence to Guide Cancer PatientsNew mobile app, guided by Artificial Intelligence (AI) offering personalized recommendations to breast cancer patients in rural Georgia has been developed. | Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
The first large-scale, collaborative, open analysis of genomic data provides a cloud-based resource for researchers looking for more comprehensive data on pediatric brain tumors.
The mission of Axiom Space incorporated numerous experiments focusing on human stem cell aging, inflammation, and cancer within the laboratory situated in the low Earth orbit.
Providing a sustained supply of hydrogen sulfide to cancer cells, could be a remodeling strategy to improve photothermal therapy efficacy while minimizing side effects.
Colon cancer's hidden link revealed in microbiome study.
Breast cancer patients in the obese or overweight category can greatly benefit from a telephone-based weight management program in achieving significant weight loss.